Asuragen Information:

Asuragen Diagnostics

Asuragen Services

Site Search

Scientific Library

If you would like a hard copy or have any inquiries regarding the literature below please contact us.

Assay Controls   |   BCR/ABL1 Quant   |   Fragile X   |   KRAS/BFAF  |   Leukemia
miRNA Biomarkers   |   Molecular Methods   |   NPM1   |   Tools

Assay Controls Normalization of microRNA quantitative RT-PCR data in reduced scale experimental designs. Latham G 2011
Assay Controls PowerAssist™: A Microarray QC Tool Pasloske BL 2010
Assay Controls DNA bacteriophage as controls for clinical viral testing Walkerpeach CR 2004
Assay Controls Ribonuclease-resistant RNA controls and standards Brown D 2001
Assay Controls Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus Walkerpeach CR 1999
Assay Controls Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards Pasloske BL 1998
BCR/ABl1 Quant
Establishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR–ABL1 on the international reporting scale 		J.T.Brown 2011
BCR/ABl1 Quant Development and evaluation of a quantitative multiplex assay for the harmonization of BCR-ABL1 measurement on the international reporting scale PubMed | Poster J.T.Brown 2010
BCR/ABl1 Quant Evaluation of BCR/ABL1 Quant Assay (RUO)* for the Quantitative Detection of e1a2, b2a2, and b3a2 Fusion Transcripts Frank Buccini 2009
BCR/ABl1 Quant Development of Armored RNA Quant® Reference Materials for the Standardization of Quantitative BCR/ABL1 Testing Emmanuel Labourier 2009
BCR/ABl1 Quant Evaluation of Asuragen’s qRT-PCR BCR/ABL Assay (RUO)* for the Quantitative Multiplex Detection of BCR/ABL1 (e1a2, b2a2, b3a2) and ABL1 Transcripts Crystal Weatherill 2008
Fragile X Assessments of the AGG Structure in 892 Samples Reveals the Risks of Expansion for Intermediate and Small Premutation Fragile X Alleles Hadd, et al. 2011
Fragile X A Sensitive and High Throughput PCR Method that Accurately Sizes FMR1 Alleles, Reproducibly Detects Fragile X Full Mutation Expansions, and Determines FMR1 Methylation Status Hadd, et al. 2011
Fragile X
High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses 		Chen, et al. 2011
Fragile X Evaluation of a CGG Repeat Primed PCR system designed for detection of Fragile X expanded alleles in clinical prenatal samples
Seneca, et al. 2011
Fragile X A PCR-only Workflow for FMR1 Analysis that Amplifies Fragile X Full Mutation Alleles, Definitively Resolves Allele Zygosity, and Accurately Assesses Methylation Status
 Gary J. Latham 2010
Fragile X A Novel PCR Technology that Identifies AGG Interruptions in the Triplet Repeat Region of the Fragile X Gene
 Gary J. Latham 2010
Fragile X Analysis of an Interesting Fragile X Family
 Wilkie 2010
Fragile X
An Information-Rich CGG Repeat Primed PCR That Detects the Full Range of Fragile X Expanded Alleles and Minimizes the Need for Southern Blot Analysis
 Liangjing Chen 2010
Fragile X Applications of Novel PCR Technologies that Provide Enhanced Molecular Characterization of the Fragile X Gene
 Andrew Hadd 2010
Fragile X PCR assay for FMR1 used to determine the incidence of expansions in early menopause in the Breakthrough Generations Study Poster | Abstract
Bennett 2010
Fragile X Reducing the need to Southern blot for Fragile X; an evaluation of the Asuragen AmplideX FMR1 kit
 Ibberson 2010
Fragile X Toward elimination of Southern blot analysis for fragile X syndrome: a rapid and sensitive PCR-based assay for simultaneous detection of expanded alleles and accurate sizing of alleles with repeats in the normal to permutation range in the FMR1 Gene
 C. A. Stolle, et al. 2010
Fragile X Validation of two new PCR technologies for diagnostic testing of the Fragile X CGG repeat as well as FMR1 methylation status
 Elles M.J. Boon 2010
Fragile X A Novel FMR1 PCR Method for the Routine Detection of Low Abundance Expanded Alleles and Full Mutations in Fragile X Syndrome
 Stela Filipovic-Sadic 2010
Fragile X Accurate Fragile X Triplet Repeat Sizing and Archival Storage from a Range of Clinically Accessible Biosamples
 Andrew Hadd 2008
KRAS/BRAF Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
 Laosinchai-Wolf W. 2011
KRAS/BRAF Signature® Technology Platform for the Rapid Multiplex Detection of Mutations in Solid Tumor Specimens
 Andrew Hadd 2010
KRAS/BRAF KRAS/BRAF Genotyping in Metastatic Colorectal Cancer: Comparison of Results Obtained with a SNaPshot® Assay and the Signature® KRAS/BRAF Mutations Assay
 Aude Lamy 2010
Leukemia Multi-Site Evaluation of a Multiplex Assay for the Rapid Detection of Leukemia-Associated Fusion Transcripts
 Christopher D. Gocke1 2011
Leukemia A comparative analysis of molecular genetic and conventional cytogenetic detection of diagnostically important translocations in more than 400 cases of acute leukemia, highlighting the frequency of false-negative conventional cytogenetics.
Rebecca L. King 2011
Leukemia A Multiplex Bead Array-based Assay for Rapid Identification of Common Leukemia Associated Translocations
 R. Luthra 2005
miRNA Biomarkers Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages Ranqel-Salazar R 2011
miRNA Biomarkers A Multi-center Study of a MicroRNA-based Assay for Diagnosis of Pancreatic Ductal Adenocarcinoma in Fine Needle Aspirates Szafranska-Schwarzbach A 2011
miRNA Biomarkers Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma. Szafranska-Schwarzbach AE 2011
miRNA Biomarkers A Global View of miRNA Expression Using a Microarray Platform Featuring Probes for More than 15,000 Putative and Validated miRNAs Sekinger E 2010
miRNA Biomarkers microRNAs as Biomarkers in Blood and Other Biofluids Kemppainen J 2010
miRNA Biomarkers Expression Profiling and Functional Studies Reveal a Potential Role for microRNAs in Human Acute Myeloid Leukemia Labourier E 2010
miRNA Biomarkers MicroRNA Isolation and Analysis from Human Whole Blood Kemppainen J 2010
miRNA Biomarkers Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways JP Cogswell 2008
miRNA Biomarkers Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling Szafranska AE 2008
miRNA Biomarkers Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues Szafranska AE 2008
miRNA Biomarkers The let-7 microRNA represses cell proliferation pathways in human cells Johnson CD 2007
miRNA Biomarkers Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway Ovcharenko D 2007
miRNA Biomarkers MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma Szafranska AE 2007
miRNA Biomarkers The colorectal microRNAome Cummins JM 2006
Molecular Methods A novel mean-centering method for normalizing microRNA expression from high-throughput RT-qPCR data. Wylie D 2011
Molecular Methods Two Complementary and Scalable PCR-based Workflows Enable Next Generation Sequencing of Cancer-Associated Genes in FFPE Tumor DNA Gary Latham 2011
Molecular Methods Performance evaluation of commercial miRNA expression array platforms. Sah S 2010
Molecular Methods Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues Peltier HJ 2008
Molecular Methods Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues Doleshal M 2008
Molecular Methods Analyzing micro-RNA expression using microarrays Davison TS 2006
Molecular Methods RNA extraction for arrays Madabusi LV 2006
Molecular Methods The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements Shi L 2006
Molecular Methods Using RNA sample titrations to assess microarray platform performance and normalization techniques Shippy R 2006
Molecular Methods High-throughput RNAi screening in vitro: from cell lines to primary cells Ovcharenko D 2005
Molecular Methods An optimized isolation and labeling platform for accurate microRNA expression profiling Shingara J 2005
NPM1 EPerformance and Clinical Evaluation of a Sensitive Multiplex Assay for the Rapid Detection of Common NPM1 Mutations
Michael Hafez 2010
NPM1 Evaluation of Signature® NPM1 Mutations (RUO)* for the Rapid Multiplex Detection of NPM1 Exon12 Mutations
 Keith Jackson 2008
Tools International standards and reference materials for quantitative molecular infectious disease testing.
 Madej RM 2010
Tools Molecular Characterization of DNA, mRNA and miRNA Biomarkers in Preoperative Fine Needle Aspirates Collected in RNARetain® Pre-Analytical Solution
 Emmanuel Labourier 2010
Tools Validation and Performance Characteristics of RNARetainTM Pre-analytical RNAStabilization Solution for Collection and Storage of Human Cellular and Tissue Specimens
 Emmanuel Labourier 2008
Tools DNA Bacteriophage as Controls for Clinical Viral Testing
 Walkerpeach CR 2004
Tools Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards.
 Pasloske BL. 1998

Select your region

Map of the world

Select your region below to learn more about Asuragen’s technology and scientific expertise as well as information about products available in your region.